Search by Drug Name or NDC

NDC 00173-0889-13 Krintafel 150 mg/1 Details

Krintafel 150 mg/1

Krintafel is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GlaxoSmithKline LLC. The primary component is TAFENOQUINE SUCCINATE.

MedlinePlus Drug Summary

Tafenoquine (Krintafel) is used to prevent the return of malaria (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) in people 16 years of age and older who are infected and are currently receiving chloroquine or hydroxychloroquine to treat malaria. Tafenoquine (Arakoda) is used alone to prevent malaria in travelers who visit areas where malaria is common. Tafenoquine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.

Related Packages: 00173-0889-13
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Tafenoquine

Product Information

NDC	00173-0889
Product ID	0173-0889_1dd2f8a0-1100-4410-ad7a-37d769fc0c35
Associated GPIs	13000070200320
GCN Sequence Number	078674
GCN Sequence Number Description	tafenoquine succinate TABLET 150 MG ORAL
HIC3	W4A
HIC3 Description	ANTIMALARIAL DRUGS
GCN	45043
HICL Sequence Number	045121
HICL Sequence Number Description	TAFENOQUINE SUCCINATE
Brand/Generic	Brand
Proprietary Name	Krintafel
Proprietary Name Suffix	n/a
Non-Proprietary Name	tafenoquine succinate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, FILM COATED
Route	ORAL
Active Ingredient Strength	150
Active Ingredient Units	mg/1
Substance Name	TAFENOQUINE SUCCINATE
Labeler Name	GlaxoSmithKline LLC
Pharmaceutical Class	n/a
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA210795
Listing Certified Through	2024-12-31

Package

NDC 00173-0889-13 (00173088913)

Pricing Information	N/A
NDC Package Code	0173-0889-13
Billing NDC	00173088913
Package	30 TABLET, FILM COATED in 1 BOTTLE (0173-0889-13)
Marketing Start Date	2019-01-22
NDC Exclude Flag	N